Aleksandra A Pandyra Selected Research

Aleksandra A Pandyra Research Topics

Disease

10	Infections 01/2022 - 02/2013
9	Neoplasms (Cancer) 01/2022 - 07/2007
5	Virus Diseases (Viral Diseases) 01/2019 - 06/2014
3	Melanoma (Melanoma, Malignant) 01/2022 - 01/2020
3	Vesicular Stomatitis 01/2018 - 02/2015
2	Cholestasis 01/2020 - 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2022
1	Leukemia 10/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2020
1	Multiple Myeloma 10/2020
1	Hematologic Neoplasms (Hematological Malignancy) 10/2020
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 02/2020
1	Intellectual Disability (Idiocy) 01/2020
1	Necrosis 01/2020
1	Bacterial Infections (Bacterial Infection) 01/2020
1	Hyperglycemia 01/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2019
1	Arenaviridae Infections 01/2018
1	Inflammation (Inflammations) 01/2018
1	Iron Deficiencies 01/2018
1	Sepsis (Septicemia) 11/2015
1	Breast Neoplasms (Breast Cancer) 09/2015
1	Hyperbilirubinemia 01/2015
1	Liver Diseases (Liver Disease) 01/2015
1	Anemia 01/2015
1	Septic Shock (Toxic Shock Syndrome) 02/2013

Drug/Important Bio-Agent (IBA)

4	Interferon Type IIBA 01/2018 - 05/2015
3	CytokinesIBA 01/2022 - 02/2013
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2007
3	Antiviral Agents (Antivirals)IBA 01/2019 - 06/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2020 - 09/2015
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2018 - 11/2015
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2022
1	Hematoxylin (Haematoxylon)IBA 04/2022
1	CaspasesIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2020
1	16S Ribosomal RNAIBA 10/2020
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 10/2020
1	Phosphodiesterase InhibitorsIBA 10/2020
1	Cilostazol (Pletal)FDA LinkGeneric 10/2020
1	Adenosine Monophosphate (AMP)IBA 10/2020
1	Dipyridamole (Persantine)FDA LinkGeneric 10/2020
1	Cyclic AMP (AMP, Cyclic)IBA 10/2020
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2020
1	Phosphotransferases (Kinase)IBA 02/2020
1	Antineoplastic Agents (Antineoplastics)IBA 02/2020
1	Serotonin ReceptorsIBA 02/2020
1	Serotonin (5 Hydroxytryptamine)IBA 02/2020
1	VemurafenibIBA 02/2020
1	Serotonin Receptor Agonists (Serotonin Receptor Agonist)IBA 02/2020
1	Caspase 3 (Caspase-3)IBA 02/2020
1	cobimetinibIBA 02/2020
1	Caspase 8 (Caspase-8)IBA 02/2020
1	Pharmaceutical PreparationsIBA 02/2020
1	tegaserod (Zelnorm)FDA Link 02/2020
1	GlycogenIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Fragile X Mental Retardation ProteinIBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	AntibodiesIBA 01/2020
1	Etanercept (Enbrel)FDA Link 10/2019
1	AntigensIBA 01/2019
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2018
1	CatecholaminesIBA 01/2018
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2018
1	InterferonsIBA 01/2018
1	LithiumIBA 01/2018
1	LeptinIBA 01/2018
1	MineralocorticoidsIBA 01/2018
1	Phosphates (Orthophosphate)IBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	VaccinesIBA 01/2017
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 09/2015
1	Fluvastatin FDA Link 09/2015
1	EnzymesIBA 09/2015
1	Mevalonic Acid (Mevalonate)IBA 09/2015
1	Oxidoreductases (Dehydrogenase)IBA 09/2015
1	SterolsIBA 09/2015
1	B-Cell Activation Factor ReceptorIBA 05/2015
1	Neutralizing AntibodiesIBA 02/2015
1	CEACAM1 ProteinIBA 02/2015
1	BilirubinIBA 01/2015
1	LipopolysaccharidesIBA 02/2013
1	Messenger RNA (mRNA)IBA 07/2007
1	Indicators and Reagents (Reagents)IBA 07/2007
1	Thymidylate SynthaseIBA 07/2007

Therapy/Procedure

4	Immunotherapy 01/2022 - 01/2020
4	Ligation 01/2020 - 01/2015
3	Therapeutics 02/2020 - 07/2007